PIONEERING PREVENTIVE NEUROMEDICINE & NEUROTHERANOSTICS

dna neuro research

ENABLING & ACCELERATING PREVENTIVE NEUROMEDICINE AND NEUROTHERANOSTICS

NGF proprietary platforms allow:

  • Personalizing neuronal screening and treatment using cutting-edge stem cell therapy
  • Targeting neuronal pathway and processes to improve neuron health
  • Screening most potent neuroactives for preventive neuromedicine and neurological disorder treatment
  • Engineering at the molecular level for neuronal targeting delivery and rescue
  • Scavenging neurotoxins by potent antioxidants and neuroprotective compounds

Testimonials

I had pressure on the left side of my brain. After using C'Neuros for 3 days I feel the pressure is lesser. Almost gone.

Bernard Chiang

I introduced my boyfriend C’Neuros and after he took it for 2 days, he can sleep well

Tan Pei Ling

I have a 10 years old son detected with autism and currently studying in a local school for special needs.

I discovered C'Neuros in Oct 2021 and started to give it to him daily in Nov 2022. After taking it for a few months, we noticed that he became more interactive.

The teachers also feedback to us that he show improvement in terms of interaction and attention lately as well.

Jordan Tan

Digital Entreprenuer

I give my kids C’Neuros everyday for better memory, focus and analytical powers.

Mrs. Lim

I have been undergoing dialysis for 2 years and I felt pain from my head down to my spine.

The doctors were afraid to inject me with sedatives as my body kept jerking involuntarily which may bend the needle. I was then given
medication but the effect wasn’t long-lasting.

Then my friend, Mei Hua, told me about Avita’s NGF &  I took it daily before I sleep. It calms my body down. I can finally lie on the bed and sleep well.

Janet Foo

LATEST NEWS

Here are our news on the business and technology development.

Please subscribe to receive the latest update

1 Feb 2020

 

Collaboration With National University of Singapore (NUS)

1 Feb 2020

 

Collaboration With NUSMETICS

1 Feb 2020

 

Collaboration With National Addictive Manufacturing Innovation Cluster